Matthew Phillip Sinnreich - 13 Oct 2022 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
President and Acting CEO, Director
Signature
/s/ Dale S. Bergman as attorney-in-fact for Matthew Sinnreich
Issuer symbol
ZEOX
Transactions as of
13 Oct 2022
Net transactions value
-$800
Form type
4
Filing time
17 Oct 2022, 06:00:44 UTC
Previous filing
26 Jul 2022
Next filing
03 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock, $0.001 par value Sale $800 -20,000 -0.29% $0.0400 6,976,000 13 Oct 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power.

Remarks:

Exhibit List - Exhibit 24 Power of attorney